MS patients may receive less frequent rituximab infusions without increasing their chances of relapse or disease progression, ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...

RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval ...

ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

SINGAPORE: When Madhivadhana Sathiyamoorthi was 4 years old, playing with a puzzle made of magnetic beads almost killed her. Her family had to rush her to a nearby polyclinic where an X-ray ...

Randomized controlled trials are clinical trials in which at least two interventions — the test treatment and a control treatment — are simultaneously evaluated in two or more arms of the ...

On Jan. 1, 2025, Christina Noonan joined Charles Shriver and Toby Thompson as a portfolio manager on the T. Rowe Price Spectrum series of funds. She also joined the duo as the third co-chair of ...

Acute respiratory distress syndrome (ARDS) is a diffuse, acute, inflammatory lung disease characterized by a severe respiratory failure. Recognizing and promptly treating ARDS is critical to combat ...

Staph (staphylococcal) infection stages range from mild to extremely serious and even life-threatening. However, if you catch and treat it early, you can keep it from becoming more serious. Caused by ...